Metoprolol Succinate ER

Toprol XL

Strengths & Sizes

Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-589-01
  • UPC Code331722589017
  • Imprint7 5/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-589-05
  • UPC Code331722589055
  • Imprint7 5/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-589-10
  • UPC Code331722589109
  • Imprint7 5/J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-590-01
  • UPC Code331722590013
  • Imprint7 6/J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-590-05
  • UPC Code331722590051
  • Imprint7 6/J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-590-10
  • UPC Code33172259105
  • Imprint7 5/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-591-01
  • UPC Code331722591010
  • Imprint7 7/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-591-05
  • UPC Code331722591058
  • Imprint7 7/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-591-10
  • UPC Code331722591102
  • Imprint7 7/J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-592-01
  • UPC Code331722592017
  • Imprint7 8/ J
Metoprolol Succinate ER
Metoprolol Succinate ER

Note: product and packaging images are not actual size

  • NDC#31722-592-05
  • UPC Code331722592055
  • Imprint7 8/J

Indications

Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: • Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) • Angina Pectoris. (1.2) • Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure (1.3)